Explore
13D/13G Activist Filings
120,255 resultsSome filings may show "N/A" for ticker if the subject is a private fund, SPAC, or unlisted security.
| Filed ↓ | Ticker | Company | Filer | Form | % Owned | Shares |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | SLNO | Soleno Therapeutics, Inc. | Vivo Opportunity Fund Holdings, L.P. | 13G/A | 4.2% | 2.3M |
| Nov 14, 2025 | KANT | Kineta, Inc./DE | Armistice Capital, LLC | 13G/A | 3.6% | 1.8M |
| Nov 14, 2025 | N/A | Barings Capital Investment Corp | Cliffwater Corporate Lending Fund | 13G/A | 13.4% | 4.3M |
| Nov 14, 2025 | UNCY | Unicycive Therapeutics, Inc. | Vivo Opportunity Fund Holdings, L.P. | 13G/A | 10.0% | 6.1M |
| Nov 14, 2025 | EKSO | MacKenzie Realty Capital, Inc. | Armistice Capital, LLC | 13G/A | 5.0% | 93K |
| Nov 14, 2025 | PTHS | Pelthos Therapeutics Inc. | Ikarian Capital, LLC | 13G/A | 6.1% | 186K |
| Nov 14, 2025 | IMUX | ONTRAK INC | Armistice Capital, LLC | 13G/A | 5.0% | 372K |
| Nov 14, 2025 | OFIX | Orthofix Medical Inc. | Armistice Capital, LLC | 13G/A | 5.7% | 2.2M |
| Nov 14, 2025 | EVO | Evotec SE | Novo Holdings A/S | 13G/A | 5.3% | 9.4M |
| Nov 14, 2025 | VYGR | Voyager Therapeutics, Inc. | Armistice Capital, LLC | 13G/A | 7.6% | 4.2M |
| Nov 14, 2025 | AEMD | Aethlon Medical, Inc. | Ikarian Capital, LLC | 13G/A | 2.0% | 15K |
| Nov 14, 2025 | SVM | SILVERCORP METALS INC | Amplify Junior Silver Miners ETF, a series of the Amplify ETF Trust | 13G | 5.0% | 11.0M |
| Nov 14, 2025 | VRCA | Verrica Pharmaceuticals Inc. | Armistice Capital, LLC | 13G/A | 6.8% | 639K |
| Nov 14, 2025 | N/A | VISTA CREDIT STRATEGIC LENDING CORP. | Cliffwater Corporate Lending Fund | 13G/A | 9.1% | 2.7M |
| Nov 14, 2025 | ZBIO | Zenas BioPharma, Inc. | Novo Holdings A/S | 13G/A | 4.7% | 2.0M |
| Nov 14, 2025 | VNRX | VOLITIONRX LTD | Armistice Capital, LLC | 13G/A | 8.7% | 9.4M |
| Nov 14, 2025 | RDWR | RADWARE LTD | Amplify Cybersecurity ETF, a series of the Amplify ETF Trust | 13G | 5.0% | 2.2M |
| Nov 14, 2025 | IBIO | IBIO, Inc. | Ikarian Capital, LLC | 13G/A | 5.0% | 1.2M |
| Nov 14, 2025 | TVTX | TRAVERE THERAPEUTICS, INC. | Armistice Capital, LLC | 13G/A | 7.5% | 6.7M |
| Nov 14, 2025 | RLMD | Relmada Therapeutics, Inc. | Ikarian Capital, LLC | 13G | 4.8% | 3.5M |
| Nov 14, 2025 | EXK | ENDEAVOUR SILVER CORP. | Amplify Junior Silver Miners ETF, a series of the Amplify ETF Trust | 13G | 6.0% | 17.5M |
| Nov 14, 2025 | TMCI | TREACE MEDICAL CONCEPTS, INC. | Armistice Capital, LLC | 13G/A | 10.0% | 6.3M |
| Nov 14, 2025 | N/A | AB Private Lending Fund | Equitable Holdings, Inc. | 13G | 86.4% | 4.4M |
| Nov 14, 2025 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Armistice Capital, LLC | 13G/A | 5.1% | 2.8M |
| Nov 14, 2025 | AVTX | Avalo Therapeutics, Inc. | Ikarian Capital, LLC | 13G/A | 3.8% | 712K |
| Nov 14, 2025 | PMN | PROMIS NEUROSCIENCES INC. | Armistice Capital, LLC | 13G/A | 5.5% | 3.0M |
| Nov 14, 2025 | BBBY | Bed Bath & Beyond Inc | Amplify Transformational Data Sharing ETF, a series of the Amplify ETF Trust | 13G | 6.5% | 4.5M |
| Nov 14, 2025 | REKR | Kartoon Studios, Inc. | Armistice Capital, LLC | 13G/A | 5.0% | 2.5M |
| Nov 14, 2025 | PDSB | STAAR SURGICAL CO | Armistice Capital, LLC | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | CAMP | CAMP4 THERAPEUTICS CORPORATION | AH Bio Fund I, L.P. | 13G/A | 3.4% | 1.6M |
| Nov 14, 2025 | SDOT | Sadot Group Inc. | Armistice Capital, LLC | 13G/A | 5.0% | 55K |
| Nov 14, 2025 | MOBX | ROCKWELL MEDICAL, INC. | Armistice Capital, LLC | 13G/A | 5.0% | 1.8M |
| Nov 14, 2025 | MTSR | Metsera, Inc. | ARCH Venture Fund XII, L.P. | 13D/A | 0.0% | 0 |
| Nov 14, 2025 | SATS | EchoStar CORP | Darsana Capital Partners LP | 13G/A | 4.8% | 7.5M |
| Nov 14, 2025 | MKZR | Rigel Pharmaceuticals, Inc. | Armistice Capital, LLC | 13G/A | 4.0% | 724K |
| Nov 14, 2025 | LMFA | Rani Therapeutics Holdings, Inc. | Armistice Capital, LLC | 13G/A | 5.0% | 2.5M |
| Nov 14, 2025 | KURA | PTC THERAPEUTICS, INC. | Armistice Capital, LLC | 13G/A | 4.1% | 3.3M |
| Nov 14, 2025 | ANY | ARGO BLOCKCHAIN PLC | Armistice Capital, LLC | 13G/A | 0.0% | 0 |
| Nov 14, 2025 | WATT | Energous Corporation | Armistice Capital, LLC | 13G | 10.0% | 185K |
| Nov 14, 2025 | RAPT | RAPT Therapeutics, Inc. | ORBIMED ADVISORS LLC | 13G/A | 6.6% | 1.1M |
| Nov 14, 2025 | SQFT | Presidio Property Trust, Inc. | Armistice Capital, LLC | 13G | 10.0% | 161K |
| Nov 14, 2025 | SNGX | SOLIGENIX, INC. | Armistice Capital, LLC | 13G | 6.7% | 708K |
| Nov 14, 2025 | MOBX | STRYVE FOODS | Armistice Capital, LLC | 13G | 10.0% | 439K |
| Nov 14, 2025 | REVB | REVELATION BIOSCIENCES, INC. | Armistice Capital, LLC | 13G | 10.0% | 251K |
| Nov 14, 2025 | MOBX | MOBIX LABS | Armistice Capital, LLC | 13G | 8.4% | 4.6M |
| Nov 14, 2025 | VOR | VOR BIOPHARMA INC. | RA Capital Management, L.P. | 13D/A | 9.9% | 2.3M |
| Nov 14, 2025 | LCTX | Lineage Cell Therapeutics, Inc. | BROADWOOD PARTNERS, L.P. | 13D/A | 23.0% | 57.5M |
| Nov 14, 2025 | NSPR | InspireMD, Inc. | OrbiMed Advisors LLC | 13G/A | 4.1% | 2.1M |
| Nov 14, 2025 | CCCC | C4 Therapeutics, Inc. | OrbiMed Advisors LLC | 13G/A | 2.3% | 1.7M |
| Nov 14, 2025 | AIRS | Airsculpt Technologies, Inc. | THRIVENT FINANCIAL FOR LUTHERANS | 13G/A | 8.6% | 5.3M |